Legend Biotech Corp. (LEGN)
28.12
+1.18
(+4.38%)
USD |
NASDAQ |
May 20, 16:00
27.66
-0.46
(-1.64%)
After-Hours: 06:50
Legend Biotech Total Liabilities (Quarterly) : 629.02M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Imunon, Inc. | 4.659M |
| Capricor Therapeutics, Inc. | 47.58M |
| Viking Therapeutics, Inc. | 106.32M |
| Protagonist Therapeutics, Inc. | 41.99M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.597B |
| Shareholders Equity (Quarterly) | 967.73M |
| Debt to Equity Ratio | 0.4023 |
| Current Ratio | 2.127 |
| Net Debt Paydown Yield | -0.23% |